Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exercise | 19 | 2022 | 203 | 5.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 132 | 3.160 |
Why?
|
| Obesity | 17 | 2023 | 356 | 2.970 |
Why?
|
| Insulin Resistance | 9 | 2022 | 79 | 2.630 |
Why?
|
| Mitochondria | 3 | 2020 | 12 | 1.390 |
Why?
|
| Blood Glucose | 5 | 2020 | 106 | 1.370 |
Why?
|
| Football | 6 | 2020 | 24 | 1.360 |
Why?
|
| Exercise Therapy | 5 | 2020 | 13 | 1.250 |
Why?
|
| C-Reactive Protein | 5 | 2017 | 96 | 1.100 |
Why?
|
| Humans | 39 | 2024 | 14077 | 1.090 |
Why?
|
| Inflammation | 5 | 2022 | 103 | 1.040 |
Why?
|
| Interleukin-6 | 5 | 2022 | 50 | 1.040 |
Why?
|
| Muscle, Skeletal | 3 | 2021 | 14 | 1.020 |
Why?
|
| Insulins | 1 | 2022 | 3 | 0.840 |
Why?
|
| Subcutaneous Fat, Abdominal | 3 | 2022 | 7 | 0.810 |
Why?
|
| Phospholipids | 2 | 2021 | 13 | 0.800 |
Why?
|
| Adiposity | 2 | 2022 | 95 | 0.800 |
Why?
|
| Mitochondria, Muscle | 1 | 2021 | 2 | 0.760 |
Why?
|
| Sarcopenia | 1 | 2021 | 7 | 0.760 |
Why?
|
| Resistance Training | 3 | 2022 | 5 | 0.730 |
Why?
|
| Female | 19 | 2022 | 8751 | 0.720 |
Why?
|
| Middle Aged | 12 | 2022 | 3425 | 0.700 |
Why?
|
| Depression | 1 | 2021 | 117 | 0.680 |
Why?
|
| Male | 14 | 2022 | 6489 | 0.670 |
Why?
|
| Adipose Tissue | 6 | 2022 | 51 | 0.660 |
Why?
|
| Sports | 2 | 2020 | 43 | 0.620 |
Why?
|
| Leptin | 2 | 2014 | 26 | 0.590 |
Why?
|
| Exercise Test | 2 | 2014 | 12 | 0.580 |
Why?
|
| Insulin | 5 | 2022 | 72 | 0.570 |
Why?
|
| Adult | 13 | 2021 | 5664 | 0.560 |
Why?
|
| Signal Transduction | 1 | 2016 | 33 | 0.550 |
Why?
|
| Fatty Acids | 4 | 2020 | 12 | 0.530 |
Why?
|
| Cross-Sectional Studies | 6 | 2022 | 1377 | 0.530 |
Why?
|
| Young Adult | 11 | 2021 | 2357 | 0.510 |
Why?
|
| Body Mass Index | 4 | 2022 | 312 | 0.490 |
Why?
|
| Glucose Tolerance Test | 3 | 2021 | 32 | 0.480 |
Why?
|
| Subcutaneous Fat | 4 | 2022 | 9 | 0.480 |
Why?
|
| Physical Conditioning, Human | 1 | 2014 | 2 | 0.480 |
Why?
|
| Body Composition | 5 | 2024 | 150 | 0.470 |
Why?
|
| Vitamin D Deficiency | 2 | 2024 | 27 | 0.460 |
Why?
|
| Oxygen Consumption | 4 | 2017 | 15 | 0.410 |
Why?
|
| Metabolic Syndrome | 2 | 2022 | 63 | 0.390 |
Why?
|
| Heart Rate | 3 | 2016 | 32 | 0.370 |
Why?
|
| Cross-Over Studies | 3 | 2016 | 37 | 0.350 |
Why?
|
| Overweight | 1 | 2010 | 84 | 0.350 |
Why?
|
| Athletic Performance | 2 | 2020 | 6 | 0.340 |
Why?
|
| Australia | 4 | 2022 | 46 | 0.310 |
Why?
|
| Physical Exertion | 3 | 2017 | 3 | 0.300 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2017 | 44 | 0.300 |
Why?
|
| Glucose | 2 | 2022 | 45 | 0.260 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 449 | 0.260 |
Why?
|
| Accelerometry | 2 | 2022 | 19 | 0.250 |
Why?
|
| Bicycling | 2 | 2014 | 6 | 0.240 |
Why?
|
| Cholestanes | 1 | 2024 | 2 | 0.240 |
Why?
|
| Fractures, Bone | 1 | 2024 | 21 | 0.230 |
Why?
|
| Sleep | 2 | 2021 | 35 | 0.230 |
Why?
|
| Aged | 4 | 2021 | 1650 | 0.230 |
Why?
|
| Intra-Abdominal Fat | 2 | 2020 | 15 | 0.220 |
Why?
|
| Hydrocortisone | 2 | 2014 | 10 | 0.220 |
Why?
|
| Ergometry | 2 | 2013 | 2 | 0.220 |
Why?
|
| Risk Factors | 3 | 2022 | 1431 | 0.220 |
Why?
|
| C-Peptide | 1 | 2022 | 13 | 0.210 |
Why?
|
| Proteomics | 1 | 2022 | 13 | 0.210 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2022 | 1 | 0.210 |
Why?
|
| Cytokines | 2 | 2014 | 107 | 0.210 |
Why?
|
| Environmental Exposure | 1 | 2023 | 45 | 0.200 |
Why?
|
| MicroRNAs | 1 | 2022 | 32 | 0.200 |
Why?
|
| Waist Circumference | 3 | 2022 | 53 | 0.200 |
Why?
|
| Jet Lag Syndrome | 2 | 2020 | 2 | 0.200 |
Why?
|
| Africa South of the Sahara | 1 | 2023 | 328 | 0.200 |
Why?
|
| Biomarkers | 2 | 2013 | 322 | 0.190 |
Why?
|
| Cell Respiration | 1 | 2021 | 1 | 0.190 |
Why?
|
| Absorptiometry, Photon | 1 | 2021 | 83 | 0.190 |
Why?
|
| South Africa | 6 | 2024 | 7312 | 0.190 |
Why?
|
| Food Supply | 1 | 2021 | 29 | 0.190 |
Why?
|
| Sleep Hygiene | 1 | 2020 | 1 | 0.190 |
Why?
|
| Air Travel | 1 | 2020 | 4 | 0.190 |
Why?
|
| Transcription Factors | 2 | 2020 | 7 | 0.190 |
Why?
|
| Light | 1 | 2020 | 11 | 0.180 |
Why?
|
| Erythrocytes | 1 | 2020 | 11 | 0.180 |
Why?
|
| Hyperinsulinism | 1 | 2020 | 4 | 0.180 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 7 | 0.180 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 41 | 0.180 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 4 | 0.180 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 11 | 0.180 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 367 | 0.170 |
Why?
|
| African Americans | 1 | 2020 | 47 | 0.170 |
Why?
|
| Epidemics | 1 | 2020 | 64 | 0.170 |
Why?
|
| Quality of Life | 1 | 2021 | 170 | 0.170 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 235 | 0.170 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 405 | 0.160 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 9 | 0.160 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2016 | 5 | 0.160 |
Why?
|
| Soccer | 1 | 2018 | 10 | 0.160 |
Why?
|
| Sports Medicine | 1 | 2018 | 19 | 0.150 |
Why?
|
| High-Intensity Interval Training | 1 | 2017 | 1 | 0.150 |
Why?
|
| Fructose | 1 | 2017 | 1 | 0.140 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2017 | 2 | 0.140 |
Why?
|
| Prevalence | 1 | 2021 | 1149 | 0.140 |
Why?
|
| Dietary Sugars | 1 | 2017 | 7 | 0.140 |
Why?
|
| Health Promotion | 1 | 2018 | 108 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 46 | 0.140 |
Why?
|
| Rest | 1 | 2016 | 2 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 2 | 0.140 |
Why?
|
| Muscle Contraction | 1 | 2016 | 5 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 7 | 0.140 |
Why?
|
| RNA, Messenger | 1 | 2016 | 32 | 0.140 |
Why?
|
| Smoking | 1 | 2016 | 99 | 0.130 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2015 | 1 | 0.130 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 1 | 0.130 |
Why?
|
| MEF2 Transcription Factors | 1 | 2015 | 1 | 0.130 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2015 | 2 | 0.130 |
Why?
|
| PPAR gamma | 1 | 2015 | 3 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 9 | 0.120 |
Why?
|
| Waist-Hip Ratio | 1 | 2014 | 22 | 0.120 |
Why?
|
| Adiponectin | 1 | 2014 | 15 | 0.120 |
Why?
|
| Cholecalciferol | 2 | 2024 | 8 | 0.120 |
Why?
|
| New South Wales | 1 | 2013 | 4 | 0.120 |
Why?
|
| Blood Chemical Analysis | 1 | 2013 | 14 | 0.120 |
Why?
|
| Vitamin D | 2 | 2024 | 39 | 0.110 |
Why?
|
| Dietary Supplements | 2 | 2024 | 40 | 0.110 |
Why?
|
| Double-Blind Method | 2 | 2024 | 263 | 0.110 |
Why?
|
| Child | 3 | 2024 | 2180 | 0.110 |
Why?
|
| Homeostasis | 1 | 2012 | 9 | 0.100 |
Why?
|
| Population | 1 | 2010 | 5 | 0.090 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2020 | 3 | 0.090 |
Why?
|
| Time Factors | 1 | 2010 | 503 | 0.080 |
Why?
|
| Motivation | 2 | 2020 | 56 | 0.080 |
Why?
|
| Diet | 2 | 2021 | 108 | 0.080 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 24 | 0.080 |
Why?
|
| HIV Infections | 1 | 2024 | 4946 | 0.070 |
Why?
|
| Calcifediol | 1 | 2024 | 6 | 0.060 |
Why?
|
| Bone Remodeling | 1 | 2024 | 11 | 0.060 |
Why?
|
| Spirometry | 1 | 2024 | 12 | 0.060 |
Why?
|
| Vitamins | 1 | 2024 | 23 | 0.060 |
Why?
|
| Bone Density | 1 | 2024 | 103 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 237 | 0.050 |
Why?
|
| Lipids | 1 | 2022 | 81 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 17 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2022 | 168 | 0.050 |
Why?
|
| Scotland | 1 | 2021 | 5 | 0.050 |
Why?
|
| Switzerland | 1 | 2021 | 2 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 190 | 0.050 |
Why?
|
| Eating | 1 | 2021 | 16 | 0.050 |
Why?
|
| Athletes | 1 | 2020 | 20 | 0.050 |
Why?
|
| Genotype | 1 | 2022 | 430 | 0.050 |
Why?
|
| Return to Sport | 1 | 2020 | 3 | 0.050 |
Why?
|
| Buttocks | 1 | 2020 | 1 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 1 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2020 | 10 | 0.050 |
Why?
|
| Oxygen | 1 | 2020 | 25 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 20 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 40 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2020 | 19 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2020 | 42 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2019 | 13 | 0.040 |
Why?
|
| Africa | 1 | 2020 | 360 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2022 | 939 | 0.040 |
Why?
|
| Aryldialkylphosphatase | 1 | 2018 | 3 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 4 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2018 | 25 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 1131 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 34 | 0.040 |
Why?
|
| Qatar | 1 | 2017 | 1 | 0.040 |
Why?
|
| United Arab Emirates | 1 | 2017 | 1 | 0.040 |
Why?
|
| Travel | 1 | 2017 | 21 | 0.040 |
Why?
|
| Perception | 1 | 2017 | 42 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2020 | 867 | 0.040 |
Why?
|
| Reperfusion | 1 | 2017 | 1 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2017 | 6 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 23 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 45 | 0.040 |
Why?
|
| Triglycerides | 1 | 2017 | 40 | 0.040 |
Why?
|
| Myocardium | 1 | 2017 | 35 | 0.040 |
Why?
|
| Heart | 1 | 2017 | 27 | 0.040 |
Why?
|
| Carnitine | 1 | 2016 | 1 | 0.030 |
Why?
|
| Coenzyme A | 1 | 2016 | 1 | 0.030 |
Why?
|
| Malates | 1 | 2016 | 1 | 0.030 |
Why?
|
| Palmitoylcarnitine | 1 | 2016 | 1 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2016 | 1 | 0.030 |
Why?
|
| Acyl Coenzyme A | 1 | 2016 | 2 | 0.030 |
Why?
|
| Electrodes | 1 | 2016 | 7 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 2 | 0.030 |
Why?
|
| Animals | 1 | 2017 | 1063 | 0.030 |
Why?
|